Hikari Power’s NovoCure NVCR Stock Holding History

Hikari Power’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,700	Closed	-$377K	–	70
2021 Q2	$377K	Hold	1,700	–	–	0.04%	62
2021 Q1	$225K	Hold	1,700	–	–	0.02%	62
2020 Q4	$294K	Buy	+1,700	New	+$233K	0.03%	61

Other funds holding NVCR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hikari Power's NVCR Position: Q3 2021 in Review

Hikari Power sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 1,700 shares — an estimated $377K sold.

Hikari Power first reported a position in NVCR in Q4 2020 and held it in 3 quarters. The position peaked at $377K in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

Hikari Power reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
Hikari Power sold 1,700 NovoCure shares in Q3 2021, an estimated $377K.
Hikari Power first reported a position in NovoCure in Q4 2020 and held it in 3 quarters.
Hikari Power's NovoCure position peaked at $377K in Q2 2021.
317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Hikari Power's 13F filing for Q3 2021, filed 13 Oct 2021.